Ernexa director granted options for 5,944 shares
Ernexa Therapeutics Inc. (ERNA) reported that director Elena Ratner received a grant of stock options covering 5,944 shares of common stock at an exercise price of $4.57 per share.
Rhea-AI Filing Summary
Ernexa Therapeutics Inc. (ERNA) reported that director Elena Ratner received a grant of stock options covering 5,944 shares of common stock at an exercise price of $4.57 per share. Subject to continued service, one-third of the option vests on the first anniversary of the grant date, with the remaining two-thirds vesting in 24 substantially equal monthly installments through August 31, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 5,944 shares
Grant/Award
1 txn
Insider
Ratner Elena
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) F1 | 5,944 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 5,944 contracts (Direct)
Footnotes (1)
- F1. Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Key Figures
Stock options granted: 5,944 shares
Exercise price: $4.57 per share
Shares underlying option after transaction: 5,944 shares
+2 more
5 metrics
Stock options granted
5,944 shares
Stock Option (Right to buy) grant to director Elena Ratner on 2026-08-31
Exercise price
$4.57 per share
Conversion or exercise price for the 5,944-share stock option grant
Shares underlying option after transaction
5,944 shares
Total stock options held from this award following the grant
Expiration date
2036-08-31
Expiration date of the reported stock option grant
Initial vesting tranche
One-third of 5,944 shares
Vests on first anniversary of grant date, subject to continued service
Key Terms
Stock Option (Right to buy), exercise price, vesting, grant date
4 terms
Stock Option (Right to buy) financial
"security_title: Stock Option (Right to buy)"
exercise price financial
"conversion or exercise price of $4.5700 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying the stock option will vest on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"on the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
What insider transaction did ERNA director Elena Ratner report on this Form 4?
Elena Ratner reported a grant of stock options for 5,944 shares of Ernexa Therapeutics Inc. common stock, with an exercise price of $4.57 per share. This is a compensation-related award rather than an open-market purchase or sale.
What is the exercise price of the stock options granted to Elena Ratner at ERNA?
The stock options granted to Elena Ratner have an exercise price of $4.57 per share. She can acquire Ernexa Therapeutics Inc. common stock at this price upon exercise of the options, subject to the vesting schedule and option terms.
What is the vesting schedule for Elena Ratner’s ERNA stock option grant?
Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date. The remaining shares will then vest in 24 substantially equal monthly installments thereafter.
When do Elena Ratner’s ERNA stock options expire?
The reported stock options granted to Elena Ratner are scheduled to expire on August 31, 2036, if not earlier exercised or forfeited according to their terms and her continued service with Ernexa Therapeutics Inc.
AI-generated analysis. How Rhea-AI works. Not financial advice.
